Savicell

Savicell is a biotechnology startup based in Israel established in 2007. The company focuses on early disease detection, particularly cancer, with its innovative Well-Shield™ platform. Savicell's liquid ImmunoBiopsy™ technology aims to identify various diseases and track treatment effectiveness, including immunotherapy, in the underserved cancer liquid biopsy market. The company's approach is based on the understanding that metabolic changes in the immune system impact immune response outcomes, allowing for disease-specific identification based on unique immune metabolic profiles. By measuring these energy changes, Savicell's Liquid ImmunoBiopsy can distinguish between and within various ailments, such as cancers, autoimmune diseases, and infectious diseases. With its groundbreaking technology and strategic focus on early disease detection, Savicell is poised to make a significant impact in the biotechnology and healthcare industries.